Oruka Therapeutics (ORK) Prices $700M Stock Offering at $72.50

Oruka Therapeutics (ORK) has priced a stock offering totaling $700 million at a price of $72.50 per share. This capital raise is significant for the company as it will be used to support ongoing development initiatives. The offering's pricing reflects current market conditions and investor interest. The successful completion of this offering could impact Oruka's liquidity and ability to fund projects moving forward.